MedTrace Logo

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

NCT00232128 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-01-12

No results posted yet for this study

Summary

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.

Conditions

  • Pulmonary Neoplasms

Interventions

PROCEDURE

Radiofrequency Ablation of pulmonary neoplasms

Sponsors & Collaborators

  • Oncology Specialties, Alabama

    lead OTHER

Principal Investigators

  • Marshall T. Schreeder, M.D. · Comprehensive Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00232128 on ClinicalTrials.gov